期刊文献+

多发性骨髓瘤诊断与治疗的研究进展 被引量:1

Study Progress in Diagnosis and Treatment of Multiple Myeloma
下载PDF
导出
摘要 骨髓瘤是指起源于骨髓造血组织的恶性肿瘤,可以是孤立性,由于骨髓瘤可引起多发性骨损害,故临床上也常称其为多发性骨髓瘤。由于多发性骨髓瘤发病机制尚未完全明确,预后极差,所以目前该病的临床治疗和诊断一直是个难题。 Myeloma refers to malignant tumor originating from hematopoietic tissue of bone marrow,which can be isolated.As myeloma can cause multiple bone damage,it is also commonly referred to as multiple myeloma clinically.Because the pathogenesis of multiple myeloma is not completely clear and the prognosis is very poor,the clinical treatment and diagnosis of the disease have been a difficult problem.
作者 陈凯 CHEN Kai(Department of Hematology,First People's Hospital of Jiande City,Hangzhou,Zhejiang 311600,China)
出处 《大医生》 2019年第7期149-150,共2页 Doctor
关键词 多发性骨髓瘤 诊断 治疗 multiple myeloma diagnosis treatment
  • 相关文献

参考文献12

二级参考文献84

  • 1侯健,姜华.双膦酸盐类药物治疗多发性骨髓瘤骨病的评价[J].中国医院用药评价与分析,2005,5(3):138-141. 被引量:3
  • 2何群,陈方平,徐雅靖,程腊梅.纯化的自体CD34^+细胞移植治疗多发性骨髓瘤的临床观察[J].中国现代医学杂志,2005,15(15):2368-2369. 被引量:3
  • 3左长京,邵成伟,田建明,赵起,吕桃珍.肾上腺转移瘤CT引导下乙醇消融治疗[J].第二军医大学学报,2006,27(12):1358-1360. 被引量:2
  • 4Palmnbo A, Anderson K. Multiple myeloma. N Eng J Med, 2011, 364 : 1046-1060.
  • 5Attal M, Harousseau JL, Stoppa AM, et al. A prospective, ran- domized trial of autologous bone marrow transplantation and chemo- therapy in multiple myeloma. Intergroupe Francais du Mylome. N Engl J Med, 1996, 335:91-97.
  • 6Benson DM, Elder PJ, Lin TS, et al. High-dose melphalan versus busulfan, cyclophospha- mide, and etoposide as preparative regi- mens for autologous stem cell transplantation in patients with multi- ple myeloma. Leukemia Res, 2007, 51:1069-1075.
  • 7Lahuerta JJ, Mateos MV, Martinez-L6pez J, et al. Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diag- nosed multiple myeloma patients included in the PETHEMA/ GEM2000 study. Haematologica, 2010, 95:1913-1920.
  • 8Durie BGM, Harousseau JL, Miguel .IS, et al. International uni- form response criteria for multiple myeloma. Leukemia, 2006, 20 : 1467-1473.
  • 9Kroger N, Hoffknecht M, I-Ianel M, et al. Busulfan, cyclophos- phamide and etoposide as high-dose conditioning therapy in pa- tients with malignant lymphoma and prior dose-limiting radiation therapy. Bone Marrow Transplant, 1998, 21: 1171-1175.
  • 10Cogle CR, Moreb JS, Leather HL, et al. Busulfan, cyclophospha- mide, and etoposide as conditioning for autologous stem cell trans- plantation in multiple myeloma. Am J Hematol, 2003, 73:169- 175.

共引文献109

同被引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部